抗支糖浆治疗小儿支气管哮喘80例临床疗效分析

doi:10.3969/j.issn.1006-6233.2017.07.026

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1367 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To observe the clinical effect of KangZhiTangJiang for the treatment of children bronchial asthma. Methods: 80 children with bronchial asthma were randomly divided into treatment group and control group, each group 40 cases. The control group was treated with western medicine, such as relieving spasm, relieving asthma and resolving phlegm. The treatment group was treated with antispasmodic, antiasthmatic, expectorant and other conventional western medicine combined with anti syrup therapy. The two groups were treated for 7 days. TCM syndromes, pulmonary function changes, clinical efficacy evaluation and adverse reactions and other aspects of the difference of the two groups before and after treatment were compared. Result: The treatment group was better than the control group in the comprehensive efficacy (including the rate of display and control and the total effective rate), the improvement of TCM syndrome score, the difference was statistically significant (P<0.05). In the improvement of lung function, the treatment group was better than the control group, but there was no statistical significance. Conclusion: The clinical efficacy of the anti syrup in the treatment of bronchial asthma in children is accurate, relatively safe and small side effects, so it is worthy of clinical application.

Key words： Kangzhitangjiang Bronchial asthma The clinical effect

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://www.hbyxzzs.cn/EN/10.3969/j.issn.1006-6233.2017.07.026 OR http://www.hbyxzzs.cn/EN/Y2017/V23/I7/1143

[1] Hon KL,Leung TF,Leung AK.Clinical effectiveness and safety of montelukast in asthma[J].Drug Des Devel Ther,2014,8:839~850.
[2] Gandhi PK; Kenzik KM; Thompson LA; et al.Exploring factors influencing asthma control and asthma-specific health-related quality of life among children[J].Respir Res,2013,14:26.
[3] McIvor RA, Chapman KR. The coming of age of asthma guidelines[J].Lancet,2008,20:1021~1022.
[4] 张树君,张帆.宣肺平喘方穴位敷贴联合免疫治疗寒热错杂型儿童支气管哮喘50例[J].中医药学报,2016,44(4):94~96.
[5] 李康,秦晓华.金沸草散加减联合西药治疗咳嗽变异型哮喘42例[J].中医杂志,2014,55(2):161~163.
[6] 李冀,王艳丽,李志军,马育轩.中医药治疗哮喘的研究进展[J].中医药信息,2014,31(1):114~117.
[7] 孟莹,王有鹏,吴振辉.射干定喘汤治疗小儿哮喘发作期痰热阻肺证疗效观察[J].新中医,2014,46(8):119~120.
[8] 中华医学会儿科学分会呼吸学组,《中华儿科杂志》编委会.儿童支气管哮喘诊断与防治指南:2016年版[J].中华儿科杂志,2016,54(3):167~181.
[9] 汪受传,虞坚尔.中医儿科学[M].第3版.北京:中国中医药出版社,2012.84~90.
[10] 中华中医药学会儿科分会临床评价学组.小儿支气管哮喘中药新药临床试验设计与评价技术指南[J].药物评价研究,2015,38(2):120~127.
[11] Meltzer EO,Pearlman DS,Eckerwall G. Efficacy and safety of budesonide administered by pressurized metered dose inhaler in children with asthma[J].Ann Allergy Asthma Immunol,2015,115(6):516~522.
[12] 乐敏飞.宁波市北仑区2013-2014年儿童哮喘流行病学调查[J].中国公共卫生管理,2016,32(4):477~479.
[13] 付新,刘阳,王雪梅,等.麻杏石甘汤的研究进展[J].中医药信息,2017,34(2):126~128.
[14] 谭杰军,王甜甜,王有鹏.王有鹏教授应用辨病辨证辨体思想治疗小儿咳嗽变异性哮喘的经验[J].中国中医急症,2015,24(9):1553~1555.
[15] 李志军,马冰宇,范越.抗支糖浆治疗小儿肺炎支原体肺炎70例临床疗效分析[J].中医药学报,2016,44(6):103~105.
[16] Rogers DF. Pulmonary mucus: pediatric perspective[J].Pediatric Pulmonology,2003,36(3):178~188.
[17] Lai H, Rogers DF. New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways[J].Journal of Aerosol Medicine and Pulmonary Drug Delivery,2010,23(4):219~231